CBP-201

· Connect Biopharm LLC

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CBP-201, covering 2023-03-21 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China [Phase 2]